Another study classified triple-negative breast cancer into three distinct metabolic phenotypes based on their specific metabolic profiles, among which lipid-synthesizing triple-negative breast cancer was relatively sensitive to FASN inhibitors [153]. The gene discussed is FASN; the disease is triple-negative breast carcinoma.